Maximus (MMS) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MMS shares.
View MMS analyst ratings or view top-rated stocks.

1 brokerages have issued twelve-month target prices for Maximus' stock. Their MMS share price forecasts range from $100.00 to $100.00. On average, they expect the company's share price to reach $100.00 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for MMS or view top-rated stocks among Wall Street analysts.

Maximus' stock was trading at $73.33 at the beginning of 2023. Since then, MMS shares have increased by 15.0% and is now trading at $84.31.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our MMS earnings forecast.

Maximus, Inc. (NYSE:MMS) posted its earnings results on Wednesday, May, 3rd. The health services provider reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.02. The health services provider had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.20 billion. Maximus had a trailing twelve-month return on equity of 15.37% and a net margin of 3.62%. Maximus's quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the company earned $1.07 EPS.

Maximus announced a quarterly dividend on Tuesday, April 11th. Stockholders of record on Monday, May 15th will be given a dividend of $0.28 per share on Wednesday, May 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Friday, May 12th.
Read our dividend analysis for MMS.

ETFs with the largest weight of Maximus (NYSE:MMS) stock in their portfolio include Natixis Vaughan Nelson Mid Cap ETF (VNMC), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Fidelity Digital Health ETF (FDHT), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Fidelity Low Volatility Factor ETF (FDLO), First Trust Multi-Manager Small Cap Opportunities ETF (MMSC), Fidelity Blue Chip Value ETF (FBCV) and First Trust Horizon Managed Volatility Small/Mid ETF (HSMV).

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.33%. The dividend payout ratio is 39.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 22.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

Maximus issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $4.00-$4.30 for the period, compared to the consensus estimate of $3.61. The company issued revenue guidance of $4.85 billion-$5.00 billion, compared to the consensus revenue estimate of $4.94 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Maximus' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.77%), Victory Capital Management Inc. (11.41%), FMR LLC (9.98%), Mackenzie Financial Corp (4.39%), State Street Corp (4.32%) and Geode Capital Management LLC (2.07%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMS stock can currently be purchased for approximately $84.31.

Maximus (NYSE:MMS) has a market capitalization of $5.12 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $2.81 on an earnings per share basis.

The company employs 39,500 workers across the globe.

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.